[Correspondence] Urodynamic testing in refractory overactive bladder symptoms: the FUTURE study

We read with interest the FUTURE study by Mohamed Abdel-Fattah and colleagues, which reported on the role and cost-effectiveness of urodynamic testing in women with refractory overactive bladder compared with comprehensive clinical assessment without urodynamics.1 We commend the authors for diligently performing a robust randomised controlled trial on 1099 patients, with a high-quality control for the urodynamic traces. However, although this study is of considerable relevance in changing clinical practice, we do not believe that this study will mark the end of urodynamic testing in the evaluation of patients with refractory overactive bladder symptoms.